In a touching and compassionate gesture, Vehari Police fulfilled the dream of a brave child, Saadur Rehman, who is fighting the life-threatening illness thalassemia, by appointing him as District ...

Agios Pharmaceuticals Inc (AGIO) reports a 6% revenue increase and outlines promising pipeline developments, despite facing ...

PYRUKYND, a pyruvate kinase activator, remains the flagship product with multi-billion-dollar potential. Agios is targeting a U.S. approval for thalassemia by September 7, 2025, and a sickle cell ...

U.S. Regulatory Filing Under Active Review for Approval of PYRUKYND® (mitapivat) in Thalassemia, with PDUFA Goal Date of September 7, 2025 – – Phase 3 RISE UP Study of Mitapivat in Sickle Cell Disease ...

Department of Pediatrics, GMC Jammu in collaboration with J&K Thalassemia Welfare Society (JKTWS) organized 2-day camp for ...

"A quarter has passed since I took over as acting CEO and it has been an eventful first few months. Despite the turbulent environment, marked by geopolitical uncertainty, we are able to report our sec ...

The first patient to receive a new gene therapy at the Children's Hospital of Philadelphia is now living pain-free for the ...

On Republic Day eve 2025, the Padma Awards recognized Arijit Singh, Ricky Kej, Shekhar Kapur, and Ajith Kumar. Late ghazal ...

District Collector and IRCS President Nagarani to receive medal from Governor during World Red Cross Day celebrations in Vijayawada.

The following is a summary of “Evaluated NSUN3 in reticulocytes from HbH-CS disease that reflects cellular stress in ...

India has delivered crucial vaccines for Sickle Cell and Thalassemia to Nepal, strengthening their healthcare collaboration.

India has delivered a $2 million consignment of vaccines to Nepal to combat Sickle Cell Disease and Thalassemia, enhancing the country's healthcare efforts. The donation underscores the longstanding ...